Leah A Bogardus

Title: Leah A. Bogardus: Innovator in Virus Neutralization Assays

Introduction

Leah A. Bogardus is a notable inventor based in Rahway, NJ (US). She has made significant contributions to the field of virology through her innovative work in virus neutralization assays. Her research focuses on developing rapid and efficient methods for assessing viral infections.

Latest Patents

Leah A. Bogardus holds 1 patent for her invention titled "Virus neutralization assay utilizing imaging cytometry." This invention describes a virus reduction neutralization test (VRNT) that serves as a rapid, high-throughput alternative to traditional low-throughput and labor-intensive neutralization assays. The VRNT employs imaging cytometry to count virus-infected cells approximately one day post-infection. This approach eliminates the lengthy wait times associated with other assays, significantly reducing overall assay time and increasing throughput by at least 15-fold.

Career Highlights

Throughout her career, Leah has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme LLC and Merck Sharp + Dohme Corp. Her experience in these organizations has allowed her to contribute to advancements in viral research and assay development.

Collaborations

Leah has collaborated with esteemed colleagues such as Dengyun Sun and Kevin B. Gurney. These partnerships have further enhanced her research and innovation in the field.

Conclusion

Leah A. Bogardus is a pioneering inventor whose work in virus neutralization assays has the potential to transform the way viral infections are assessed. Her innovative approach not only streamlines the testing process but also significantly improves efficiency in virology research.